Tyme Inc, Tyme Technologies deal

Cancer company Tyme Inc. reverse merged with Tyme Technologies. Tyme Inc. shareholders hold 68 million shares of the newco, which represents a 79% stake. Tyme Technologies closed a private placement along with the merger, raising $6.8 million through the sale of 2.7 million shares at $2.50. ...